There is a new DNA sequencing instrument, the MINI, for sequencing DNA in the clinic or core research laboratory.Unlike all other DNA sequencing systems, which run only one or two samples at a time, the MINI can simultaneously run any number of flow cells between one and twenty. Each flow cell is designed to be disposable, low-cost and use very little reagent; thus, DNA from a single patient or specimen may be cost-effectively sequenced without the need for indexing multiple samples in a single flow cell. This is an important feature for the clinic, as in addition to simplifying the sample preparation process, different sample may be kept physically separate (meters) from one another, thereby significantly reducing the chance of contamination or false diagnosis. Low cost (about $100 per sequencing test) is achieved through a unique sequencing by synthesis chemistry and low reagent consumption. Parallel flow cell processing and fluidics design results in high throughput (tens of tests per day). In addition to sequence-based clinical testing, the system supports targeted resequencing up to an exome per flow cell. Read lengths are driven by application requirements and are between 35-100 bp.
SOURCES – Journal of Biomedical Technology
Written By Brian Wang, Nextbigfuture.com
Brian Wang is a Futurist Thought Leader and a popular Science blogger with 1 million readers per month. His blog Nextbigfuture.com is ranked #1 Science News Blog. It covers many disruptive technology and trends including Space, Robotics, Artificial Intelligence, Medicine, Anti-aging Biotechnology, and Nanotechnology.
Known for identifying cutting edge technologies, he is currently a Co-Founder of a startup and fundraiser for high potential early-stage companies. He is the Head of Research for Allocations for deep technology investments and an Angel Investor at Space Angels.
A frequent speaker at corporations, he has been a TEDx speaker, a Singularity University speaker and guest at numerous interviews for radio and podcasts. He is open to public speaking and advising engagements.
1 thought on “Clinical DNA Sequencer for Ultra-Low Cost Testing”
NEW? It literally says 2012 in the referenced article.
Comments are closed.